Levomine Mini (Ethinylestradiol, Levonorgestrel)

Ethinylestradiol, the active ingredient in Levomine Mini, is a combined oral contraceptive presented as an oral tablet for oral use. Together with levonorgestrel, it works to prevent pregnancy in women of reproductive age by inhibiting ovulation and altering cervical mucus.

GNH USA supplies Levomine Mini as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levomine Mini, a combined oral contraceptive, is indicated for hormonal contraception to prevent pregnancy.

Prevention of pregnancy: provides reliable contraceptive protection when taken as directed.

Levomine Mini may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild stomach upset, often resolves with continued use. - Breast tenderness: temporary swelling or discomfort. - Headache: mild to moderate intensity. - Spotting or breakthrough bleeding: irregular bleeding between periods.

Serious or Rare Side Effects: - Deep vein thrombosis: blood clot formation in leg veins. - Pulmonary embolism: clot migration to lung vessels. - Stroke or myocardial infarction: rare cardiovascular events. - Severe allergic reaction: rash, swelling, or difficulty breathing.

Before prescribing Levomine Mini, clinicians should evaluate individual risk factors and contraindications. - Contraindications: known thromboembolic disorder, estrogen‑dependent tumor, active liver disease, pregnancy, or breastfeeding. - Smoking: avoid use in women over 35 who smoke. - Cardiovascular history: assess for hypertension, diabetes, or hyperlipidaemia. - Drug interactions: review concomitant medications that may affect hormone levels. - Store at ambient temperature: keep in the original pack, protect from moisture.

Levomine Mini can interact with several medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Enzyme‑inducing anticonvulsants (e.g., carbamazepine, phenytoin): may reduce contraceptive efficacy. - Rifampin or other rifamycins: can lower hormone levels, increasing pregnancy risk. - St. John’s wort: herbal inducer that may diminish protection.

Moderate Interactions (Monitor Closely): - Certain antibiotics (e.g., tetracycline, metronidazole): may slightly decrease effectiveness. - Antifungal agents (e.g., ketoconazole, itraconazole): can increase hormone concentrations. - Diuretics: may affect fluid balance and blood pressure, requiring monitoring.